International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 2 , Pages 370-376 , 1 June 2009

Unresectable Squamous Cell Carcinoma of the Lung: An Outcomes Study

Received 22 April 2008 ,Revised 21 July 2008 ,Accepted 20 August 2008.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2007. CA Cancer J Clin. 2007;57:43–66
  2. Yang P, Allen MS, Aubry MC, et al. Clinical features of 5,628 primary lung cancer patients: Experience at Mayo Clinic from 1997 to 2003. Chest. 2005;128:452–462
  3. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group. Cancer. 1980;45:2744–2753
  4. Jett JR. Current treatment of unresectable lung cancer. Mayo Clin Proc. 1993;68:603–611
  5. Rosenthal SA, Curran WJ, Herbert SH, et al. Clinical Stage II non–small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer. 1992;70:2410–2417
  6. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable Stage III non-small-cell lung cancer. J Clin Oncol. 1999;17:2692–2699
  7. Sause W, Kolesar P, Taylor S, et al. Final results of Phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest. 2000;117:358–364
  8. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer. 1987;59:1874–1881
  9. Komaki R, Scott CB, Sause WT, et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 1997;39:537–544
  10. Huang EH, Liao Z, Cox JD, et al. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys. 2007;68:779–785
  11. Sibley GS. Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma smaller volumes and higher doses—a review. Cancer. 1998;82:433–438
  12. Libshitz HI, McKenna RJ, Mountain CF. Patterns of mediastinal metastases in bronchogenic carcinoma. Chest. 1986;90:229–232
  13. Line DH, Deeley TJ. The necropsy findings in carcinoma of the bronchus. Br J Dis Chest. 1971;65:238–242
  14. Komaki R, Swann S, Ettinger D, et al. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). [abstract] Int J Radiat Oncol Biol Phys. 2003;57
  15. Curran W, Scott C, Langer C, et al. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected Stage III NSCLC: Initial report of RTOG 9410. [abstract] Proc Am Soc Clin Oncol. 2000;19
  16. Saunders M, Dische S, Barrett A, et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol. 1999;52:137–148
  17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  18. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A Phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:318–328
  19. Socinski MA, Morris DE, Halle JS, et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation Phase I trial. J Clin Oncol. 2004;22:4341–4350
  20. Perez CA, Bauer M, Edelstein S, et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys. 1986;12:539–547
  21. Bradley JD, Graham M, Suzanne S, et al. Phase I results of RTOG L-0117; a Phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC. [abstract] J Clin Oncol. 2005;23
  22. Martel MK, Strawderman M, Hazuka MB, et al. Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol. 1997;44:23–29
  23. Rosenman JG, Halle JS, Socinski MA, et al. High-dose conformal radiotherapy for treatment of Stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a Phase I/II trial. Int J Radiat Oncol Biol Phys. 2002;54:348–356
  24. Rengan R, Rosenzweig KE, Venkatraman E, et al. Improved local control with higher doses of radiation in large-volume Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:741–747
  25. Cox JD, Pajak TF, Asbell S, et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys. 1993;27:493–498
  26. Chen M, Jiang GL, Fu XL, et al. The impact of overall treatment time on outcomes in radiation therapy for non–small cell lung cancer. Lung Cancer. 2000;28:11–19
  27. Bengtsson A, Henriksson KG. [Causes of fibromyalgia are both peripheral and central]. Lakartidningen. 1996;93:161–163
  28. Machtay M, Hsu C, Komaki R, et al. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys. 2005;63:667–671

 Conflict of interest: none.

PII: S0360-3016(08)03307-5

doi: 10.1016/j.ijrobp.2008.08.019

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 2 , Pages 370-376 , 1 June 2009

Article Tools

* Image Usage & Resolution